We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stem Cell Therapeutics Corp. Announces Top-Line Results for the Modified REGENESIS Phase IIb Stroke Trial

News   May 26, 2010

 
Stem Cell Therapeutics Corp. Announces Top-Line Results for the Modified REGENESIS Phase IIb Stroke Trial
 
 
 

RELATED ARTICLES

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

Viagra – The Little Blue Pill Could Reshape Bone Marrow Transplants

News

A study published today in the journal Stem Cell Reports suggests that a combination of two clinically approved drugs – Viagra and Plerixafor – efficiently and rapidly mobilizes blood stem cells from the bone marrow into the bloodstream in a mouse model. This combination therapy may offer a new approach for bone marrow transplants in humans.

READ MORE

A Way To Extend Survival Rates for Heart Failure?

News

For the first time in preclinical studies, researchers have shown that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay progression of congestive heart failure and extend survival rates.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE